David Sinclair and Longevity: The Documented Public Record
A clinical review of David Sinclair's publicly confirmed use of NMN, metformin, and resveratrol for longevity, with peer-reviewed context on each compound's mechanisms and evidence base.
6 source-based articles maintained by the HealthRX.com Editorial Team.

Showing 6 of 6 clinical reviews.
A clinical review of David Sinclair's publicly confirmed use of NMN, metformin, and resveratrol for longevity, with peer-reviewed context on each compound's mechanisms and evidence base.
How David Sinclair's confirmed NMN, metformin, and resveratrol regimen compares to other public longevity advocates, with clinical context from the HealthRX.com Medical Team.
Harvard longevity researcher David Sinclair has publicly confirmed taking NMN, metformin, and resveratrol for years. The HealthRX.com Medical Team examines what clinical evidence says about stopping or continuing these compounds long-term.
David Sinclair is a Harvard geneticist with 200+ peer-reviewed papers on aging who takes NMN, metformin and resveratrol; here's what the research actually supports.
Harvard geneticist David Sinclair has openly shared his NMN, metformin, and resveratrol regimen. The HealthRX.com Medical Team maps his reported side effects against peer-reviewed clinical data.
A clinical and financial breakdown of the NMN, metformin, and resveratrol regimen David Sinclair has publicly confirmed taking, with real-world cost and access data for everyday patients.